Sign In
Buy ZYXI
$0.125
+0 (+0%)
At Close: Mar 20, 2026
Zynex: A Reassessment
05:23pm, Tuesday, 03'rd Oct 2023
Zynex, Inc. is a pain management company that manufactures and markets medical devices for chronic and acute pain treatment. The stock has fallen by half since we took a first look at it in April desp
Zynex to Present at the Cantor Global Healthcare Conference
09:15am, Tuesday, 19'th Sep 2023
ENGLEWOOD, Colo. , Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex to Present at the H.C. Wainwright Global Investment Conference
09:15am, Tuesday, 05'th Sep 2023
ENGLEWOOD, Colo., Sept. 5, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex, Inc. (ZYXI) Q2 2023 Earnings Call Transcript
08:14pm, Thursday, 27'th Jul 2023
Zynex, Inc. (NASDAQ:ZYXI ) Q2 2023 Earnings Conference Call July 27, 2023 4:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive
Zynex Inc. (ZYXI) Q2 Earnings and Revenues Surpass Estimates
06:28pm, Thursday, 27'th Jul 2023
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.08 per share a year ago.
Zynex, Inc. Sets Second Quarter 2023 Earnings Call
09:15am, Thursday, 20'th Jul 2023
ENGLEWOOD, Colo. , July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex: Strong Growth And Profitability Amid Financial Concerns
03:33am, Sunday, 16'th Jul 2023
Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in net income. Despite short-term underperformance,
Why Shares of Zynex Are Up Wednesday
12:33pm, Wednesday, 14'th Jun 2023
Zynek makes electrotherapy devices to control pain. The company grew revenue and net income in the first quarter.
7 Stocks With 1,000% Upside Potential
06:34pm, Tuesday, 30'th May 2023
While market advocates will wince at accusations that investing is nothing more than legalized gambling, for these stocks with massive upside potential, I for one will have to concede that only specul
Zynex, Inc. (ZYXI) Q1 2023 Earnings Call Transcript
02:49pm, Saturday, 29'th Apr 2023
Zynex, Inc. (NASDAQ:ZYXI ) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ET Company Participants Louisa Smith - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive
Zynex Inc. (ZYXI) Beats Q1 Earnings and Revenue Estimates
07:00pm, Thursday, 27'th Apr 2023
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.03 per share a year ago.
Zynex, Inc. to Announce First Quarter 2023 Financial Results
09:15am, Wednesday, 19'th Apr 2023
ENGLEWOOD, Colo. , April 19, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex: Seems An Odd Short Target
12:23pm, Tuesday, 18'th Apr 2023
Zynex: Seems An Odd Short Target
Zynex soars after 4Q earnings and revenue beat Street estimates
03:24pm, Monday, 13'th Mar 2023
Zynex Inc shares soared after the company posted fourth quarter earnings and revenue that beat Wall Street analyst estimates. For the period ended December 31, 2022, the Englewood, Colorado-based medi
Zynex Inc. (ZYXI) Q4 Earnings Surpass Estimates
10:44am, Monday, 13'th Mar 2023
Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 5.26% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
